, 15:327
Date: 08 Dec 2012

Cardiovascular Effects of Anti-Diabetic Medications in Type 2 Diabetes Mellitus

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


Over the past several years, there have been a significant number of new agents developed for the treatment of type 2 diabetes. Our goal in this article is to review the cardiovascular effects (risks and benefits) of these oral and non-insulin injectable agents. We review six major categories of diabetic therapies: biguanides, sulfonylureas, alpha-glucosidase inhibitors, thiazolidinediones, GLP-1 agonists, and DPP-IV inhibitors. In order to achieve a personalized regimen that aims for optimal outcomes, we must take into consideration each drug’s side effects, patients’ cardiovascular risk factors, and their individual health profile.

This article is part of the Topical Collection on Diabetes and Cardiovascular Disease